CA1313485C - Detection of nucleic acid sequences using particle agglutination - Google Patents
Detection of nucleic acid sequences using particle agglutinationInfo
- Publication number
- CA1313485C CA1313485C CA000530996A CA530996A CA1313485C CA 1313485 C CA1313485 C CA 1313485C CA 000530996 A CA000530996 A CA 000530996A CA 530996 A CA530996 A CA 530996A CA 1313485 C CA1313485 C CA 1313485C
- Authority
- CA
- Canada
- Prior art keywords
- nucleic acid
- particles
- acid sequences
- sample
- bound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6816—Hybridisation assays characterised by the detection means
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Urology & Nephrology (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
DETECTION OF NUCLEIC ACID SEQUENCES USING
PARTICLE AGGLUTINATION
Abstract of the Disclosure A method of detecting, identifying and/or quantitating nucleic acids in a sample through determination of agglutination or inhibition of agglutination of suspendable particles having nucleic acids bound thereto is described. The nucleic acids can be bound directly to the particle surfaces or attached through a spacer molecule which can, in turn, be either covalently bound or adsorbed to the particle surfaces, The suspendable particles are small enough to remain in suspension and will generally have a large particle size relative to the molecular weight of the DNA or RNA attached to the surfaces. The presence or absence of nucleic acid sequences in a sample is determined by detecting agglutination or inhibition of agglutination of particles having bound thereto nucleic acid se-quences complementary to those of interest in the sample.
PARTICLE AGGLUTINATION
Abstract of the Disclosure A method of detecting, identifying and/or quantitating nucleic acids in a sample through determination of agglutination or inhibition of agglutination of suspendable particles having nucleic acids bound thereto is described. The nucleic acids can be bound directly to the particle surfaces or attached through a spacer molecule which can, in turn, be either covalently bound or adsorbed to the particle surfaces, The suspendable particles are small enough to remain in suspension and will generally have a large particle size relative to the molecular weight of the DNA or RNA attached to the surfaces. The presence or absence of nucleic acid sequences in a sample is determined by detecting agglutination or inhibition of agglutination of particles having bound thereto nucleic acid se-quences complementary to those of interest in the sample.
Description
~3~3~
DET~CTION OF NUCLEIC ACID SEQUENCES USING
PARTICLE AGGLUTINATION
Description echnical Field This invention is in the field o~ ligand assays and in particular relates to the detection and quantification of nucleic acid sequences through nucleic acid hybridization.
Background Information Wucleic acid hybridization is the basis for many methods used for the detection and identiica-tion of nucleic acids in a sample. Hybridization is the process by which a single stranded nucleic acid (i.e., D~lA or RNA) recoynizes its complementary strand and hydrogen bonds to it, forming a double stranded molecule. That is, when single stranded ;~ nucleic acids are combined under approprlate condi-; tions, complementary base sequences pair and double-stranded hybrid molecules are formed.
In nucleic acid hybridization assays (e.gO, DUA~DNA, D~-RN~), it is often the case that sample DNA or RNA is attached to a solid support (e.g., a ; cellulose nitrate filter~ by simply allowing it to adhere to the support. A labelled probe DNA or R~iA
25 is then added under conditions appropriate for hybridization of complementary sequences to occurO
The presence of sequences complementary to the probe sequence is determined by detecting binding of the labelled probe to bound (samplc) D~7~ or RN~.
rj Attachment of DNA to a solid support can be accomplished by non-specific physical adsorption o~
single stranded nucleic acid ~e.g., to nitrocellu-lose papers~ and by chemical bonding (e.g., to agarose/Sepharose~ aminoethyl-Sepharose~ Sephadexes~
cellulose).
Nucleic acid hybridization provides a very sensitive and specific approach to detecting and iden-tifying nucleic acids in samples. However, methods presently available require enzyme - or radioactive tracer - labelled nucleic acid probes, time-consuming procedures and/or sophis-ticated equipment. Presently, nucleic acid hybrids are detected by observing a change in the absorbance of a DNA solution; by physically isolating hybridized n~lA from nonhybridized D~lA using chromatography or hydroxyapatite and quantitating the hybridized DNA;
or capturing the hybridized DNA on nitrocellulose.
Generally, these methods require labeled nucleic acids because although a nucleic acid sequence will anneal only with i-ts complementary sequence, the presence of hybrid double stranded molecules is unde-tectable unless -the probe is labelled. Eor example, nucleic acid sequences are often radio-2~ actively labelled using phosphorous 32 (32p)l whichcan be introduced into DNA molecules as phosphate groups while they are being synthesized by host bacteria or by an ln vitro reaction. Radioactively labelled nucleic acid sequences are widely used, but radioactive material can pose a ris~ -to the user.
Such materials typically have short half-lives and, therefore, limited shelf lives. In addition, ~ 3 ~ 3 L~
expensive, sophisticated equipment is necessary for their detec-tion.
In European Patent Office (EPO) Application 0,130,523, Da-ttagupta and Crothers describe a solid support for nucleic acids and an immobilized nucleic acid probe capable of hybridizing with complementary nucleic acids. The solid support, to which a nucleic acid can be bound by irradiationl is des-cribed as comprising a solid substrate which has reactive groups; a photochemically reactive inter-calator compound or other ligand capable of binding nucleic acids; and a divalent radical chemically linking the solid and the nucleicacid binding ligand. Upon photoactivatioll, the ligands chemi-cally link with nucleic acids. Speci~ically, thesolid substrate is nitrocellulose paper having hydroxyl groups and linked by a bifunctional reagent to an amino-substitu-ted compound, which in turn is photochemically linked to a nucleic acid. The 20 resulting immobilized nucleic acid is described as being useful in hybridization assays in which the support with coupled DNA is mixed with an unknown (possibly containing sequences complementary to that on the support) and a detection (labelled) probe.
25 Testing the sclid support for presence of a label (e.g., radioactivity~ shows whether hybridization has occurred or not ~and thus whether complementary D~lA is present).
In EPO Applicaton 0,130,515, Dattagupta et al, 30 describe a method for de-tecting the presence in a sample of a particular nucleic acid sequence which involves dual nucleic acid hybridization. A sample ~ 3'~
containing unknown DNA is mixed with two nucleic acid probes which are complementary to two nonover-lapping por-tions of the nucleic acid sequence to be de-tected. One probe is labelled and soluble in the sample and the o-ther probe is fixed to a solid support (e.g., nitrocellulose). The ml~ture is allowed to stand under hy~ridi~ing conditions;
hybridization to both probes by DN~ in the sample occurs only if it contains sequences complementary to both probes. Separating the dual hybridization product (by separating the solid support) and detectiny the label at-tached -to it is said to provide a method of determining the presence in a sample o~ the DN~ sequence of interest.
In U.S. Patent 4,486,539, Ranki and Soderlund describe a kit for use in detect~ng and identifying viral or bacterial nucleic acids. The one-step sandwich hybridization procedure on which the kit is based requires two nucleic acid fragments from the genome of the microbe to be identified, which have no sequences in common. One fragment is Eixed to a solid carrier (e.g., a nitrocellulose filter) and the other is labelled. Contact bet~een nucleic acids to be identified and nucleic acids on the solid carrier results in annealing of complementary base pairs to form a hybrid. ~nnealing the second ~labelled) fragment to the fragment to be identified results in labelling of those fragments for~ed on the solid support and thus allows their detection 3Q and quantification.
In Patent Cooperation Treaty (PCT) W084/02721, Kohne describes a method for detecting and ~ 3 ~
quantifying bacteria and viruses containing RNA.
A~ter the nucleic acids in a sample and a marked probe (radioactively labelled nucleic acid sequences complemen-tary to the RNA of the organism to be detected) have been incubated under hybridization conditions, the degree of hybridization wi-th the marked probe is measured. The method is described as being useful for in solution hybridization or hybridization with an immobilized nucleic acid probe.
At the present time, there is a need for a method of detecting the presence of nucleic acid sequences in biological samples which has the specificity of nucleic acid hybridization tech-ni~ues, but doe~ not require -the use o~ radioactive materials, time-consuming preparation and sophisti-cated equipmen-t.
Best ~ode of Carrying Ou-t the Invention The method of this invention has very broad application, both in terms of the types of samples for which it is useful and the types of organisms which can be detected in such samples. The nucleic acid content of any type of biological sample (e.g., blood and other tissues; urine; and foodstuffs such as milk) can be determined using the present inven-tion. The presence in biological samples oE bac-teria and viruses can be detected using particle agglutination. In addition, because bacteria have common nucleic acid sequences, as well as sequences ; 30 specific to a strain or class within the species, it is possible to detect all bacteria in a sample by ~3~3l~
using a shared nucleic acid sequence or to detect specific bacteria by using a nucleic acid sequence unique to that s-train or class.
Disclosure of the Invention The present invention is based on the discovery that nucleic acid segments attached to a suspendable solid support, such as latex par~icles, and comple-mentary nucleic acid segments in solution will hybridize and cause particle agglutination. The nucleic acid segments, which can be either DNA or ~NA, thus initiate particle agglutina-tion ti-e., cause particles to agylutinate).
The invention described herein is a method of detecting, identifyiny and/or quantitating nucleic - 15 acids in a biological sample, as well as particles having nucleic acids bound thereto. The nucleic acids can be either bound directly to the particle suraces or are attached through a spacer molecule which can, in turn, be either covalently bound or 20 adsorbed to the particle surfaces. In the method of this invention, nucleic acid sequences are used either to produce agglutination of inert particles having bound thereto nucleic acid sequences comple-mentary to nucleic acid sequences to be de-tected in d 25 the sample or to interfere with agglutination of such particles.
That is, if a sample contains nucleic acid sequences complementary to those attached to the solid support, hybri~ization will occur and cause 30 particle agglutination. Alternatively, inhibition of agglutination can be used to detect the presence of nucleic acid sequences of interest in a sample.
In this case, two different nucleic acid sequences (e.g., + and -) are attached to the solid support;
that is, some of the solid support particles have ~-~) strands attached to tllem and others (-) strands.
If the sample contains nucleic acids complementary to either of the attached sequences, agglutination of the solid support is inhibited. In ei-ther case, detec-tion of the degree of agglutination can be carried out visually or by another method known in the art. The degree of agglutination is indicative of the ex-tent of hybridization of complementary nucleic acid sequences, which is, in turn, indica-tive of the presence of nucleic acid sequences in the sample.
~ s a result of this discovery, i-t is possible to detect, identify, quantify and/or isolate nucleic acids oE interest in biological samples (e.g., body fluids, tissues, foodstuffs) and other samples using techniques and equipment which do not require highly skilled personnel for successful operation. An important characteristic of the use of in solution or in suspension hybridization as described herein is that the reactants are not immobilized as, for example on large particles or filter membranes, and, as a result, hybridization occurs more rapidly because the reactive (hybridizable) sites can diffuse together more readily. The resulting speed and the specificity with which nucleic acid se-quences of interest can be detected (e.~., indiagnosing infectious diseases, detecting bacterial contaminants in foodstuffs) are important advantages ,~
~3~3~
of the present invention. In addition, no separa-tion of bound and unbound phases is required before the reaction mixture can be evaluated for hybridiza tion. Separation of the bound and unbound phases is required in other methods of performing hybridiza~
tion. In addition, because nucleic acid hybridi~a tion is highly specific - that is, a nucleic acid sequence will hybridize only with a complementar~
sequence - the particle agglutination method of the present invention is a very reliable means of "selecting" nucleic acid sequences of interest from among the numerous sequences found in biological samples. The nucleic acid sequences to be detected can be characteristic oE or shared by all members of a bac~erial or viral species; as a result, all bac-teria (or viruses) in a sample can be detected.
This is particularly useful, for example, in detect-ing all bacteria in a foodstuff (e.g., a complete plate count for bacteria present in a milk sample).
Alternatively, the nucleic acid sequences to be detected in the foodstuff can be specific to members of a given strain or class.
Brief Description of the Drawings Figure 1 is a block diagram of one embodiment o~ the method of detecting nucleic acid sequences in a sample in which nucleic acid sequences are bound to particles.
Figure 2 is a block diagram of one embodiment of the method of detecting nucleic acid sequences in a sample in which probe nucleic acid sequences are bound to particulate support material and ~L 3 ~
complementary nucleic sequences are bound to other particles.
Figure 3 is a block diagram of one,embodiment of the method of detecting nucleic acid sequences in a sample in which nucleic acid sequences comple-mentary to those to be de~ected in the sample are bound to particles.
Figure 4 is a b~ock diagram of one er~odiment of the method of detecting nucleic acid sequences in a sample in which probe nucleic acid sequences are bound to inert support material and complementary nucleic acid sequences are bound to inert support ma-terial of relatively smaller size.
Figure 5 is a block diagram of one embodiment of the method of detec~ting nucleic acid sequences in a sample in which sample nucleic acid sequences are bound to particles.
Detailed Description of the Invention According to the me-thod of the present inven-tion, detection of nucleic acids in a sample usin~agglutination of particles to which nucleic acid sequences are attached can be carried out directly or indirectly.
In the direct method, an example of which is represented in Figure 1, nucleic acid sequences complementary to those of interest are attached to latex particles and contacted with an appropriately treated sample (i.e., one which has been treated by methods known to those skilled in the art to make the nucleic acid sequences available for hybridiza-tion). Hybridization of the bound nucleic acids with those in the sample causes particle agglutina-tion; agglu-tinatiorl does not occur iE the F,equellce~
! of interest are not presen-t in the sample.
.
For example, if a solution containing one set of latex particles having nucleic acid sequences ABC
and a second se-t of la-tex particles having nucleic acid sequences DEF is contacted with a sample containing the nucleic acid sequence complementary to ABC and DEF (designated A B C D E F ), hybridiza-tion of the complementary sequences will occur.
Particle agglutination will result. If the sample does not contain the complementary sequence, hybridization and particle agglutination will not occur.
In the indirect method, an example of which is represented in Figure 2, the presence in a sample oE
the nucleic acid segments of interest inhibits lS agglutination of particles bearing complementary nucleic acid sequences. Two sets of nucleic-acid-bearing latex particles are used. For example, latex particles bearing strands of VN~ (designated +) and other latex particles bearing DNA strands complementary to (~) strands (designated ) are contacted with a sample to be analyæed for the presence of a par-ticular DNA sequence. The DNA
strands attached to some of the latex particles are complementary to the DNA to be detected in the sample. If the sample tested le.g., ~lood) contains the DNA sequence of interest, that sequence will hybridize to its complement (which is bound to latex particles) and prevent hybridization of the particlebound (~) and (-) DNA segments.
Agglutination of the particles will thus be inhibited or prevented and its absence will indicate tha-t the DNA sequence sought is present in the sample.
Nucleic Acid Segments Deoxyribonucleic acid (DNA) or ribonucleic acid (RNA~ to be used as the probe can be at-tached to a solid support or includecl in a solution which i9 contacted with the sample DNA-particle complex. It can be any gene or nucleic acid sequence (DNA or RNA) of interest. For example, it can be sequences complementary to a ribosomal RN~ sequence that is present in either all bacteria ~inclusive) or sequences complementary to a ribosomal RN~ sequence that is characteristic of a single type of bacteria (exclusive). If an inclusive ribosomal nucleic acid is used as the probe, contact with a sample contain-ing RNA from any bacteria will result in hybridi-zation and agglutination of the particles. An exclusive ribosomal probe will only agglutinate when RNA from a specific group of bacteria is present.
Because RNA is rapidly degraded when an organism dies, only viable cells will be detected. In the first case, all viable bacteria in a sample will be detect~d; in the second, only the one type of viable bacteria having ~lA complementary to the probe selected will be detected. This could be used, for example, in detecting viable bacteria in a milk sample pretreated to release bacterial RN~; it provides a simple, rapid and specific alternative to the standard plate count presently used in the dairy 3a industry. As described in greater detail in Example 1, any single strand of DNA and its complement can ~3~
be attached to the solid support~ In this case, one clone provides one DNA strand (designated +) and a second clone provides the second (or complementary) DNA strand (designated -~. For example, the src gene and the beta globin gene can be attached to -the latex particles.
The nucleic acid sequences attached to the solid suppor-t can be of almost any length. It has been demonstra-ted that a stable bond or hybrid is formed when the nucleic acid has five or more base pairs. Generally, thereore, the nucleic acid sequences bound to -the solid support will be five or more bases in length.
Nucleic acid sequences to be attached to the solid supports or use as probes can be obtained by cloning of isolated DNA or RNA segments according to methods well known in the art. See, for example, Maniatis, T. et al., Molecular Cloning - A Labora-tory Manual, Cold Spring ~larbor Laboratory (1982~.
For example, any restriction enzyme, such as EcoRI, can be used to produce a desired DNA fragment for use as a probe. sacterial DNA can be cleaved at selected sites on ei-ther side of the DNA fragment of interest; the resulting fragments of interest can be isolated from other fragments (and thus purified) elec-trophoretically. The isolated DNA fragments can then be amplified by inserting them into a plasmid or a bacterial virus ~bacteriophage~, which is in turn inserted into an appropriate bacterial host cell. As the cells con-taining the plasmid prolifer-ate, the plasmid also replicates, producing many copies of the DNA fragment to be used as a probe.
After -the cells have been allowed to proliferate, the hybrid plasmids are isolated and purified, resulting in the isolation of many copies of the DNA
fragment.
Nucleie acid sequences to be attaehed to the solid supports could also be obtained syn-thetically or, if they occur in nature in sufficient quanti-ties, simply by isolation and purification.
It is also possible to attach nueleic aeid sequenees from an appropriately treated biologieal sample to the solid supports. In this case, the nucleie aeid sequences in solution would he those eomplementary to the sequences of interest in the sample; that is, the probe sequenees would be in solution.
Solid Support ~aterials The solid support to whieh the DNA or RNA is attached can be essentially any insoluble material to which the DNA or RNA can be covalently attaehed or irreversibly adsorbed; that is, the materlal must be reactive with the D~A or RNA or must adsorb a substance which can be eovalently linked to the DNA
or RNA. The solid support can be, for example, latex, ehareoal, eolloidal gold, bentonite or glass.
In addition, silica gel, controlled pore glass, red blood eells and liposomes can be used. In faet, any such particles to which nucleic aeids can be attaehed can be employed in the applieation of the present invention. Nucleic acids have reactive amino funetional groups ? as well as terminal phos-phate groups and reaetive hydroxyl groups in the sugar "backbone". In addition, ribose in RNA
~' ~ 3 ~
can be partially cleaved oxidatively (e.g., with periodate, as in Fischer, U.S. Patent 4,264,766) to produce a reactive aldehyde function. These re-active groups on -the nuc]eic acid can be reacted wi-th reactive groups on latex or other particles.
Glass or other particles can be derivatized to form reactive functional groups (see, for example, Weetall, U.S. Patent 3,652,761; Koster, et al., Tetrahedron Letters 24: 747 (1983)~ capable of reacting with nucleic acids and proteins. Nucleic acids can also be linked directly to polystyrene (e.g. ! Ito, et al.: Nucleic Acid Research 10: 755 (1982)). The solid support need not have a particu~
lar shape (configuration) but will often be spheri-cal. It must be small enough to remain in suspen~
sion and will generally have a large particle size relative to the molecular weight of the DNA or RNA
probe (e.g., less than 500 microns).
Binding oE Probe to Solid Support Nucleic acid sequences, either DNA or RNA, are attached to a solid support. For example, they can be covalently bound the binding can occur randomly along the length of the DNA or R~A, at the 5 end or at the 3 end. The sequences can also be bound to the solid support through a protein or other spacermaterial. Previously, a carbodiimide coupling reaction has been used by those in the field for the purpose of covalently linking DNA to solid supports, such a~s agarose (Sepharose~, aminoethyl-Sepharosc~
Sephadexes and cellulose. Allfrey, V.G. and A.
Inoue, In: Methods in Cell Biology 18: 253-270 (1978), This reaction produces a phosphodiester 13 ~ r~
bond between the phosphoryl group at the 5' end o~
the DNA and hydroxyl groups on the solid matrix.
In one embodiment o~ this invention, nucleic acid sequences bound to solid supports are linked to latex particles along the length of the fragments.
One method which can be used for covalent attachment is described in detail in Example 1. Nucleic acid sequences bound to latex particles using this method appear to be covalently attached randomly along their length. The method in Example l-is based on the method for forming an amide bond between latex and protein described by Dorman in U.S. Paten-t ~,045,3a4. There are three steps to the procedure.
First, carbox~lated latex particles are activated;
tha~ is, an active est.er is formed at the latex surface through reaction wi-th a water-soluble N~hydroxy cornpound (e.g., N~hydroxybenzotriazole or N-hydroxysuccinimide) and a water-soluble carbodi-imide (e.g., l-cyclohexyl-3-[2-morpholinoethyl]-carbodiimide methyl-p-toluene sulfonate (CMC)).
These materials are combined, stirred and cooled (e.g., to abou-t 2D-50C). As a result, an anhydride link is formed between the carboxyl group of the latex particle and the hydroxy nitrogen (NOH2) group o the hydroxybenzotriazole. Next the reaction mixture containing the hydroxybenzotriazole deriva-tive attached is cleaned by dialysis. In this way, unchanged reactants (e.g., carbodiimide and by-products~ are removed. Single stranded DN~ (or ~NA) can be covalently bonded to the activated latex particle by combining the latex-hydroxybenzotriazole complex with single stranded D~lA (or ~IA) and ~L3~ 3~ ~r agitating the combination (e.g., by rocking) at room temperature. The product of this procedure has been shown to be single stranded DN~ cov~lently attached to the la-tex particle at randcm along the length of the DNA. Similarly, this can also be done using RNA.
As mentioned, nucleic acids can also be at-tached to particles by being a-ttached to other "bridging" molecules which can be adsorbed or covalently attached to latex. Nucleic acids can be ~ovalently linked to polysaccharides through one of many known reactions (Allfrey, V.G. and A. Inoue, In: Methods in Cell Bioloqy 18: 253-270 ~1978)).
Polysaccharides can be partially oxidized to yield reactive aldehyde groups whic}l can, in turn, be reacted with particles haviny suitably rcac-t:ive groups such as amino groups (e.g., amino functional latex).
DNA can be covalently attached to proteins by numerous methods ~Nucleic Acid Research, 12: 3435 (1984)) and the proteins attached to latex or other particles using well known techniques. Synthetic polymers can also be used (Nucleic A _d Research 12:
3435 (1984); Litchfield, et al.: linical Chemistry 30: 1489 ~1984)).
~Iybridization of DNA Bound to Solid Support With Complementary D~IA
There are several methods which can be used to detect nucleic acids in a sample using DNA (or RNA) probes bound to a solid support according to the present invention. These are best described with reference to the EiguresO
. . .
As shown in Figure 2, the test or probe DNA or RNA (designatecl ~BC(+)~ can be bound to support material, such as latex particles, and DNA lor RNA) complementary to the probe DMA (designated .
A B C ~-)) can be bound to other latex particles.
When the sample containlng unknown nucl~ic acid ~e.g., ribosomal RNAI is contacted with a mixture of the two nucleic acid-bearing particles under condi~
tions appropriate for hybridization to occur, if the sample nucleic acid is complementary ~e.g., A B C
to that of the probe DNA, it will interfere with agglutination of the particles bearing the comple-mentary nucleic acid sequences. Particle agglutin-ation will be inhibited. The extent o interference with par-ticle agglutination is directly related to the amount of complementary nucleic acids in the sample. If there are only a few complementary sequences in the sample, particle agglutination will be interefered with to a lesser extent than if the sample contains a large number of sequences comple-mentary to sequences on the latex particles.
In another embodiment of the method of this invention, represented in Figure 1, probe nucleic acid is covalently bound to all latex particles.
The presence of complementary nucleic acid sequences in a sample will be detected when the latex parti-cles agylutinate. For example, one group of latex particles can have the nucleic acid sequences represented by ABC bound to them and another group sequences represented by D~ bound to them. I~ the sample nucleic acid contains the complementary sequences to ABCDEF le.g-, A B C D E F ) ~ 3 ~ c~
hybridization of the sample nucleic acids A B C
with the ABC on one par-ticle and of the sample nucleic acids ~ E F with the DEF on another particle will occur. As a result, agglutination of the particles will also occur. As shown in Figure 3, this would also occur if all latex particles have the entire sequence (ABCDEF) bound to them and the sample nucleic acids have the complementary sequences (A B C D E F ).
lOIn a further embodiment, represen~ed in Figure 4, particles of two different sizes can be used for -the attachment of probe DNA. For example, probe DNA
can be a-ttached to the larger partieles and its complement to the smaller particles. In the pre-senee of eomplementary DN~ or RNA in the sample, small partieles would not be agylutinated to large partieles and would pass through a filter of selected pore size. If the eomplementary sequences ; are not present in the sample, the probe DNA (bound to the larger particles) and its complement which is bound to the smaller partieles will hybridize, preventing the small partieles from passing through the filter.
It is also possible using the method of this invention to attach the unknown or sample nueleie aeid DNA or RNA to an aetivated latex particle.
This is represented in Figure 5. In this case, a specifie probe in solution is contaeted with the sample DNA-particle complex; the probe used can be tagged for purposes of detecting its presence. If the sample DNA or ~NA is complementary to the probe ~ 3 ~
D~A or RNA, hybridization of the nucleic acids and agglutination of the par-ticles will occur.
Measurement of Agglutination or ~ggrega~ion of Particles Having Bound DNA or ~NA as an Indica-tor of the Presence of Comp~ementary Sequences in a Sample Determination of agglutinatiorl or aggregation of particles having covalen-tly-bound DNA or RNA can be carried out by any method capable of detecting the degree of agglutination present after sample and probe have been contacted under conditions appropri-ate for hybridization to occur. For example, it can be carried out visually using the unaided eye (e.g., v.isualization against a black or other dark back-ground); microscopically; or by turbidimetricmeasurements. In addition, a particle counter having a size -threshhold can be used to detect aggregated/unaggregated particles. Selective counting techniques, which are well known in the art, make it possible -to count the number of part-icles in a given size range and -thus allow quanti~
tative assays to be carried out. See, for example, U.S. Patent 4,184,849 to C.~. Cambiaso et al., in which such techniques are described. It is also possible to use a ~ilter having a defined pore size;
the pore size is selected so as to allow nonaggre-gated particles to pass through but to prevent aggregated particles from doing so. See, for example, U.S. Patent 4,459,361 to ~I.L. Gefter.
Although it is possible, using filtration, to separate agglutinated particles from unagglutinated particles ~and thus detect hybridization of ~ 3 1 ~
-2~-complementary sequences), this approach is limi-ted in that the number of particles present must be large enough to allow visual detection. It is possible, however, using known -techniques, to enhance the visibility of the particles through selection of such properties as color, optical density and fluorescence. The particles can be enz~me labeled in such a way that the enzymes attached to the particle surfaces catalyze a color-producing change (thus aiding particle detection). Such amplification techniques are particularly useful when the nucleic acid sequences of in-terest are present in a sample in low concentratiolls.
This invention will now be more specifically described by the following examples.
Example 1 A. Preparation of single stranded complementary DNA
To prepare single stranded complementary DNA, the following method was used. A DNA sequence ~i~e., a portion of the src gene) was cloned into an ~13 bacteriophage using protocols described previ-ously. ~u, N. and J. Messing, The making of strand-25 -specific M13 probes. Gene, 17:271-277 (1982);
Messing, J., New M13 vectors for cloning, Methods in Enzymology-Recombinant DNA Techniques _:20-77 (1981). Two clones were isolated which contain the sequence cloned in opposite directions. The bac-teriophage produced by one of these clones contains single-stranded D~lA molecules which is partially ~3~ 3~$~
complementary to the DNA molecule of the other clone. The methods for using, cloning and growing commercially available M13 bacteriophage vectors exist (Amersham). For simplicity, (-~ is used to describe one ~13 bacteriophage cloned DN~ and (-) to describe the cloned DNA which contains its comple~
ment. Therefore, ~+) and (-) strands of DNA can hybridize by hydrogen bonding. Another method is to isolate the complementary DNA strands by preparative electrophoresis as described by Maniatls and co-workers. Maniatis, T. et al., Molecular Cloning - A
Laboratory Manual, Cold Spring Harbor Laboratory (1982).
B. A tivation of Carboxylated Latex Carboxylated latex used as the solid support in covalent binding with D~A was prepared according to the following technique, which is based on the method described by Dorman in U.S. Patent 4,045,384.
Activation of the carboxyl groups results from the reaction of the carboxylate latex with N-l-hydroxy-benzotriazole in the presence of CMC, according to the following reaction:
~3 1~3~
o~, o~
C
C~
~C-o~ 3 ) C-o- C, ~J ~ IJ
~ llo~
,~
-C-~H-C~J,C1~ l .
~3~L3~
Specifically, 0.2 ml. of an ~ hydroxybenzo-triazole solution was added to I ml. of carboxylate la-tex (1 microrl in diameter, 2.5% solids). (The N
hydroxybenzotriazole solution was made by dissolving 93 mg. of Aldrich ~-hydroxybenzotriazole in 1.6 ml.
dimethylformamide; this was diluted to 4 ml. with water.) The combination was placed in an ice water bath and 0.1 ml. of CMC (100 mg. CMC solution in 2 ml. water at 0C) was added dropwise. The mixture was stirred in the cold Eor four hours or overnight.
Cleaning of the latex (removal of the unreacted products of the reaction, e.g., urea, as shown above) was accomplished by dialyzing the mix-ture overnight agains~ 0.1 molar (M) sodium chloride (~laCl) at 4C. An additional 2 ml. of O.lM NaCl was added to the dialysis bag.
The mix-ture was placed in Eppendorf -tubes (1 ml. each) and sonicated for 10 seconds. They were spun and resuspended three times in water and then resuspended in 50 mM phosphate buffer at pH 8Ø
Covalent Bonding of D~lA -to the Modified Latex DNA to be bonded to the latex particles was added to the dialyzed particles described above.
The DNA prepared as in part A was added while the 2S particles were being stirred in an ice water bath or at 5~ Also present at that time was 1 m1. of pll 8.0 phospha-te buffer and 0.1 ~I NaCl solution. About 0.06 ml. of the N-hydroxybenzotriazole solution (prepared as described above) was also added to aid the forward reaction. The pll of the mixture ~G.83 was raised to 7.2 by the addition of 0.5~1 dibasic sodium phosphate. The mixture was stirred for 5 ~3~$~
-2~-days at about 4C and washed with clistilled water containing azide.
Evaluation of the la-tex par-ticles prepared according to the method described above was carried out. The latex particles were spun down in Eppen-dorf tubes and washed three times with 0.1~ SDS;
each time -they were resuspended in 1 ml. of 0.1~
SDS. Microscopic assessment showed that most of the particles were monomers or dimers.
D. Agglutination of Latex Partieles by Hybridiza-tiOIl of (~) Stand Covalently Bound -to Latex to (-) Strand DNA in Solution -llybridization of (~) strand DNA to (-~) strand DNA covalently bound -to latex partieles was carried out. About 0.1 ml of latex (2~ solids) to whi.ch (-~) strand DNA was covalently bound was placed ln each of three tubes. The solid latex particles were pelleted by cen-trifugation and resuspended in 50 mieroliters of 0.4~!1 sodium phosphate buffer ip~ 7.8) and 0.1~ SDS containing one o the following:
o DNA
(2) (+) strand DNA (0.5 micrograms) (3) (-) strand DNA (0.5 micrograms) The three tubes were incubated at 60C for 10 to 12 hours. ~fter the incubation the latex was pelleted again and resuspended in 0.1~ SDS.
Approximately 10 microliters were placed on a glass microscope slide and examined microscopically under oil immersion at 100 X m~gni~ication under ~ cover slip. The examination showed the following: (1) Mostly monomeric: a few climers (2~ ~lostly monomer~s;
--~s-a few dimers (3) Few monomers; many particles in which 4 to 10 latex particles have agglutinated.
These results demonstrate tha-t (-) strand DNA in solution can cause latex which has (~) strand DNA
covalently attached to it -to agglut;Lnate.
Example 2 The procedure described in Example 1 was used excep-t that -the latex preparation was re~uspended in 50 microliters of 0.4 M sodium phosphate bu~fer, 0.1~ SDS containing tl) Denatured calf thymus DNA (1.5 ug) (2) (-~ strand DNA (5 ug) (3) (-) strand DPlA (0.5 ug) -~ calf thymus DNA
(1.5 ug) ~Iicroscopic observations showed the followiny:
(1~ Mos-tly monomers; a few dimers (2) Very large aggregates; many greater than 50-100 particles, visible using the unaided eye (3) Few monomers; many aggregates (having) 4 to 6 latex particles.
These results demonstrate that: (1) non-complemen-tary DNA will not cause DNA which has (+) strand DNA
covalently bound to it to agglutinate; (2) a large amount of ~-) strand DNA (5 ug) in solution will cause a lot of visible agglutination while a little ; (-) strand DNA in solu-tion (0.5 ug) will cause only a little agglutination; (3) heterologous, noncomple-mentary thymus DNA will not interfere with agglutination of lateY. with (+) strand DNA
covalently attached to it by ~-) strand DNA in solution.
!l .
~ 3 ~
-2~-The main conclusion to he drawn from bo-th of these examples is that under the conditions des-cribed DNA in solution can hybridize to comple-mentary DNA attached to a solid support and cause the latex to agglutinate.
Example 3 Detection of Nucleic Acid Sequences In A
Biological Sample Vsing Covalently Bound DNA
Sequences RNA can be extracted from a sample of milk and used to cause the agglutination of a latex that has a probe specific for ribsomal RNA (vRNA3 attached to it. Such a probe is DNA or ~NA complemen-tary to the sequences of vRNA of organisms which occur in milk.
This can be carried out as follows:
(1) To 10 ml of skim milk add SDS to 0.1~, Proteinase K to 200 ug/ml (2) Incubate at 60~C overnight (3) Add 10 ml of liquified equilibrated phenol (4) Extract and centrifuge (5) Remove aqueous phase and add DNase to 100 ug/ml (6) Repeat steps 3 and 4 (7) Take aqueous phase; add 10 ml of isoamyl alcohol and chloroform mixed in a 1 to 24 volume/volume mixture (8) Repeat step 4 (9) Repeat steps 7 and 8 ~10) Remove aqueous phase and bring to 0.1 ~l sodium chloride. Add 20 mls ethyl alcohol (11) Bring to -20C for 10~12 hours (12) Centrifuge at 15, noo g.
(13) ~esuspend pellet in 5~ microliters containillg 0.4 t~ pllo~L~Ilate ~uffer, O.l~
~ 3 ~
SDS and latex with a rRN~ probe covalently attached as described in example lB.
(14~ Incubate at 60C for 10 to 12 hours (15) Observe the latex microscopically or visually Visual (microscopic) evaluation shows that there are few monomers; most are 5 to 100 agglutinated latex particles.
Industrial Applicability Nucleic acid probes and hybridization assays according to this invention have a variety of possible applications in which the ability to detect, quantify and/or identify complementary nucleic acid sequences of interest .in biological samples of all kinds is of great value. For ex-ample, they are useEul in a research context as tools for studying gene structure and inheritance.
In addition, they are useful in clinical settings for the detection and identification of infectious agents and for prenatal diagnosis of genetic dis-orders. Finally, DNA probes have utility in the diagnosis of cancer (by providing information on the structure of oncogenes); in tissue typing; in veterinary and plant diagnos-tics; and in food testing (by providing a quicker, more convenient means of testing for the presence of pathogens~.
Equivalents Those skilled in the art will recognize, or be able to ascertain using no more than routine experi-mentation, many equivalents to the specific \
~3~3~
embodiments of the invention described herein. Such equivalen-ts are intended -to be encompassed by the following cl.aims.
.
' .
DET~CTION OF NUCLEIC ACID SEQUENCES USING
PARTICLE AGGLUTINATION
Description echnical Field This invention is in the field o~ ligand assays and in particular relates to the detection and quantification of nucleic acid sequences through nucleic acid hybridization.
Background Information Wucleic acid hybridization is the basis for many methods used for the detection and identiica-tion of nucleic acids in a sample. Hybridization is the process by which a single stranded nucleic acid (i.e., D~lA or RNA) recoynizes its complementary strand and hydrogen bonds to it, forming a double stranded molecule. That is, when single stranded ;~ nucleic acids are combined under approprlate condi-; tions, complementary base sequences pair and double-stranded hybrid molecules are formed.
In nucleic acid hybridization assays (e.gO, DUA~DNA, D~-RN~), it is often the case that sample DNA or RNA is attached to a solid support (e.g., a ; cellulose nitrate filter~ by simply allowing it to adhere to the support. A labelled probe DNA or R~iA
25 is then added under conditions appropriate for hybridization of complementary sequences to occurO
The presence of sequences complementary to the probe sequence is determined by detecting binding of the labelled probe to bound (samplc) D~7~ or RN~.
rj Attachment of DNA to a solid support can be accomplished by non-specific physical adsorption o~
single stranded nucleic acid ~e.g., to nitrocellu-lose papers~ and by chemical bonding (e.g., to agarose/Sepharose~ aminoethyl-Sepharose~ Sephadexes~
cellulose).
Nucleic acid hybridization provides a very sensitive and specific approach to detecting and iden-tifying nucleic acids in samples. However, methods presently available require enzyme - or radioactive tracer - labelled nucleic acid probes, time-consuming procedures and/or sophis-ticated equipment. Presently, nucleic acid hybrids are detected by observing a change in the absorbance of a DNA solution; by physically isolating hybridized n~lA from nonhybridized D~lA using chromatography or hydroxyapatite and quantitating the hybridized DNA;
or capturing the hybridized DNA on nitrocellulose.
Generally, these methods require labeled nucleic acids because although a nucleic acid sequence will anneal only with i-ts complementary sequence, the presence of hybrid double stranded molecules is unde-tectable unless -the probe is labelled. Eor example, nucleic acid sequences are often radio-2~ actively labelled using phosphorous 32 (32p)l whichcan be introduced into DNA molecules as phosphate groups while they are being synthesized by host bacteria or by an ln vitro reaction. Radioactively labelled nucleic acid sequences are widely used, but radioactive material can pose a ris~ -to the user.
Such materials typically have short half-lives and, therefore, limited shelf lives. In addition, ~ 3 ~ 3 L~
expensive, sophisticated equipment is necessary for their detec-tion.
In European Patent Office (EPO) Application 0,130,523, Da-ttagupta and Crothers describe a solid support for nucleic acids and an immobilized nucleic acid probe capable of hybridizing with complementary nucleic acids. The solid support, to which a nucleic acid can be bound by irradiationl is des-cribed as comprising a solid substrate which has reactive groups; a photochemically reactive inter-calator compound or other ligand capable of binding nucleic acids; and a divalent radical chemically linking the solid and the nucleicacid binding ligand. Upon photoactivatioll, the ligands chemi-cally link with nucleic acids. Speci~ically, thesolid substrate is nitrocellulose paper having hydroxyl groups and linked by a bifunctional reagent to an amino-substitu-ted compound, which in turn is photochemically linked to a nucleic acid. The 20 resulting immobilized nucleic acid is described as being useful in hybridization assays in which the support with coupled DNA is mixed with an unknown (possibly containing sequences complementary to that on the support) and a detection (labelled) probe.
25 Testing the sclid support for presence of a label (e.g., radioactivity~ shows whether hybridization has occurred or not ~and thus whether complementary D~lA is present).
In EPO Applicaton 0,130,515, Dattagupta et al, 30 describe a method for de-tecting the presence in a sample of a particular nucleic acid sequence which involves dual nucleic acid hybridization. A sample ~ 3'~
containing unknown DNA is mixed with two nucleic acid probes which are complementary to two nonover-lapping por-tions of the nucleic acid sequence to be de-tected. One probe is labelled and soluble in the sample and the o-ther probe is fixed to a solid support (e.g., nitrocellulose). The ml~ture is allowed to stand under hy~ridi~ing conditions;
hybridization to both probes by DN~ in the sample occurs only if it contains sequences complementary to both probes. Separating the dual hybridization product (by separating the solid support) and detectiny the label at-tached -to it is said to provide a method of determining the presence in a sample o~ the DN~ sequence of interest.
In U.S. Patent 4,486,539, Ranki and Soderlund describe a kit for use in detect~ng and identifying viral or bacterial nucleic acids. The one-step sandwich hybridization procedure on which the kit is based requires two nucleic acid fragments from the genome of the microbe to be identified, which have no sequences in common. One fragment is Eixed to a solid carrier (e.g., a nitrocellulose filter) and the other is labelled. Contact bet~een nucleic acids to be identified and nucleic acids on the solid carrier results in annealing of complementary base pairs to form a hybrid. ~nnealing the second ~labelled) fragment to the fragment to be identified results in labelling of those fragments for~ed on the solid support and thus allows their detection 3Q and quantification.
In Patent Cooperation Treaty (PCT) W084/02721, Kohne describes a method for detecting and ~ 3 ~
quantifying bacteria and viruses containing RNA.
A~ter the nucleic acids in a sample and a marked probe (radioactively labelled nucleic acid sequences complemen-tary to the RNA of the organism to be detected) have been incubated under hybridization conditions, the degree of hybridization wi-th the marked probe is measured. The method is described as being useful for in solution hybridization or hybridization with an immobilized nucleic acid probe.
At the present time, there is a need for a method of detecting the presence of nucleic acid sequences in biological samples which has the specificity of nucleic acid hybridization tech-ni~ues, but doe~ not require -the use o~ radioactive materials, time-consuming preparation and sophisti-cated equipmen-t.
Best ~ode of Carrying Ou-t the Invention The method of this invention has very broad application, both in terms of the types of samples for which it is useful and the types of organisms which can be detected in such samples. The nucleic acid content of any type of biological sample (e.g., blood and other tissues; urine; and foodstuffs such as milk) can be determined using the present inven-tion. The presence in biological samples oE bac-teria and viruses can be detected using particle agglutination. In addition, because bacteria have common nucleic acid sequences, as well as sequences ; 30 specific to a strain or class within the species, it is possible to detect all bacteria in a sample by ~3~3l~
using a shared nucleic acid sequence or to detect specific bacteria by using a nucleic acid sequence unique to that s-train or class.
Disclosure of the Invention The present invention is based on the discovery that nucleic acid segments attached to a suspendable solid support, such as latex par~icles, and comple-mentary nucleic acid segments in solution will hybridize and cause particle agglutination. The nucleic acid segments, which can be either DNA or ~NA, thus initiate particle agglutina-tion ti-e., cause particles to agylutinate).
The invention described herein is a method of detecting, identifyiny and/or quantitating nucleic - 15 acids in a biological sample, as well as particles having nucleic acids bound thereto. The nucleic acids can be either bound directly to the particle suraces or are attached through a spacer molecule which can, in turn, be either covalently bound or 20 adsorbed to the particle surfaces. In the method of this invention, nucleic acid sequences are used either to produce agglutination of inert particles having bound thereto nucleic acid sequences comple-mentary to nucleic acid sequences to be de-tected in d 25 the sample or to interfere with agglutination of such particles.
That is, if a sample contains nucleic acid sequences complementary to those attached to the solid support, hybri~ization will occur and cause 30 particle agglutination. Alternatively, inhibition of agglutination can be used to detect the presence of nucleic acid sequences of interest in a sample.
In this case, two different nucleic acid sequences (e.g., + and -) are attached to the solid support;
that is, some of the solid support particles have ~-~) strands attached to tllem and others (-) strands.
If the sample contains nucleic acids complementary to either of the attached sequences, agglutination of the solid support is inhibited. In ei-ther case, detec-tion of the degree of agglutination can be carried out visually or by another method known in the art. The degree of agglutination is indicative of the ex-tent of hybridization of complementary nucleic acid sequences, which is, in turn, indica-tive of the presence of nucleic acid sequences in the sample.
~ s a result of this discovery, i-t is possible to detect, identify, quantify and/or isolate nucleic acids oE interest in biological samples (e.g., body fluids, tissues, foodstuffs) and other samples using techniques and equipment which do not require highly skilled personnel for successful operation. An important characteristic of the use of in solution or in suspension hybridization as described herein is that the reactants are not immobilized as, for example on large particles or filter membranes, and, as a result, hybridization occurs more rapidly because the reactive (hybridizable) sites can diffuse together more readily. The resulting speed and the specificity with which nucleic acid se-quences of interest can be detected (e.~., indiagnosing infectious diseases, detecting bacterial contaminants in foodstuffs) are important advantages ,~
~3~3~
of the present invention. In addition, no separa-tion of bound and unbound phases is required before the reaction mixture can be evaluated for hybridiza tion. Separation of the bound and unbound phases is required in other methods of performing hybridiza~
tion. In addition, because nucleic acid hybridi~a tion is highly specific - that is, a nucleic acid sequence will hybridize only with a complementar~
sequence - the particle agglutination method of the present invention is a very reliable means of "selecting" nucleic acid sequences of interest from among the numerous sequences found in biological samples. The nucleic acid sequences to be detected can be characteristic oE or shared by all members of a bac~erial or viral species; as a result, all bac-teria (or viruses) in a sample can be detected.
This is particularly useful, for example, in detect-ing all bacteria in a foodstuff (e.g., a complete plate count for bacteria present in a milk sample).
Alternatively, the nucleic acid sequences to be detected in the foodstuff can be specific to members of a given strain or class.
Brief Description of the Drawings Figure 1 is a block diagram of one embodiment o~ the method of detecting nucleic acid sequences in a sample in which nucleic acid sequences are bound to particles.
Figure 2 is a block diagram of one embodiment of the method of detecting nucleic acid sequences in a sample in which probe nucleic acid sequences are bound to particulate support material and ~L 3 ~
complementary nucleic sequences are bound to other particles.
Figure 3 is a block diagram of one,embodiment of the method of detecting nucleic acid sequences in a sample in which nucleic acid sequences comple-mentary to those to be de~ected in the sample are bound to particles.
Figure 4 is a b~ock diagram of one er~odiment of the method of detecting nucleic acid sequences in a sample in which probe nucleic acid sequences are bound to inert support material and complementary nucleic acid sequences are bound to inert support ma-terial of relatively smaller size.
Figure 5 is a block diagram of one embodiment of the method of detec~ting nucleic acid sequences in a sample in which sample nucleic acid sequences are bound to particles.
Detailed Description of the Invention According to the me-thod of the present inven-tion, detection of nucleic acids in a sample usin~agglutination of particles to which nucleic acid sequences are attached can be carried out directly or indirectly.
In the direct method, an example of which is represented in Figure 1, nucleic acid sequences complementary to those of interest are attached to latex particles and contacted with an appropriately treated sample (i.e., one which has been treated by methods known to those skilled in the art to make the nucleic acid sequences available for hybridiza-tion). Hybridization of the bound nucleic acids with those in the sample causes particle agglutina-tion; agglu-tinatiorl does not occur iE the F,equellce~
! of interest are not presen-t in the sample.
.
For example, if a solution containing one set of latex particles having nucleic acid sequences ABC
and a second se-t of la-tex particles having nucleic acid sequences DEF is contacted with a sample containing the nucleic acid sequence complementary to ABC and DEF (designated A B C D E F ), hybridiza-tion of the complementary sequences will occur.
Particle agglutination will result. If the sample does not contain the complementary sequence, hybridization and particle agglutination will not occur.
In the indirect method, an example of which is represented in Figure 2, the presence in a sample oE
the nucleic acid segments of interest inhibits lS agglutination of particles bearing complementary nucleic acid sequences. Two sets of nucleic-acid-bearing latex particles are used. For example, latex particles bearing strands of VN~ (designated +) and other latex particles bearing DNA strands complementary to (~) strands (designated ) are contacted with a sample to be analyæed for the presence of a par-ticular DNA sequence. The DNA
strands attached to some of the latex particles are complementary to the DNA to be detected in the sample. If the sample tested le.g., ~lood) contains the DNA sequence of interest, that sequence will hybridize to its complement (which is bound to latex particles) and prevent hybridization of the particlebound (~) and (-) DNA segments.
Agglutination of the particles will thus be inhibited or prevented and its absence will indicate tha-t the DNA sequence sought is present in the sample.
Nucleic Acid Segments Deoxyribonucleic acid (DNA) or ribonucleic acid (RNA~ to be used as the probe can be at-tached to a solid support or includecl in a solution which i9 contacted with the sample DNA-particle complex. It can be any gene or nucleic acid sequence (DNA or RNA) of interest. For example, it can be sequences complementary to a ribosomal RN~ sequence that is present in either all bacteria ~inclusive) or sequences complementary to a ribosomal RN~ sequence that is characteristic of a single type of bacteria (exclusive). If an inclusive ribosomal nucleic acid is used as the probe, contact with a sample contain-ing RNA from any bacteria will result in hybridi-zation and agglutination of the particles. An exclusive ribosomal probe will only agglutinate when RNA from a specific group of bacteria is present.
Because RNA is rapidly degraded when an organism dies, only viable cells will be detected. In the first case, all viable bacteria in a sample will be detect~d; in the second, only the one type of viable bacteria having ~lA complementary to the probe selected will be detected. This could be used, for example, in detecting viable bacteria in a milk sample pretreated to release bacterial RN~; it provides a simple, rapid and specific alternative to the standard plate count presently used in the dairy 3a industry. As described in greater detail in Example 1, any single strand of DNA and its complement can ~3~
be attached to the solid support~ In this case, one clone provides one DNA strand (designated +) and a second clone provides the second (or complementary) DNA strand (designated -~. For example, the src gene and the beta globin gene can be attached to -the latex particles.
The nucleic acid sequences attached to the solid suppor-t can be of almost any length. It has been demonstra-ted that a stable bond or hybrid is formed when the nucleic acid has five or more base pairs. Generally, thereore, the nucleic acid sequences bound to -the solid support will be five or more bases in length.
Nucleic acid sequences to be attached to the solid supports or use as probes can be obtained by cloning of isolated DNA or RNA segments according to methods well known in the art. See, for example, Maniatis, T. et al., Molecular Cloning - A Labora-tory Manual, Cold Spring ~larbor Laboratory (1982~.
For example, any restriction enzyme, such as EcoRI, can be used to produce a desired DNA fragment for use as a probe. sacterial DNA can be cleaved at selected sites on ei-ther side of the DNA fragment of interest; the resulting fragments of interest can be isolated from other fragments (and thus purified) elec-trophoretically. The isolated DNA fragments can then be amplified by inserting them into a plasmid or a bacterial virus ~bacteriophage~, which is in turn inserted into an appropriate bacterial host cell. As the cells con-taining the plasmid prolifer-ate, the plasmid also replicates, producing many copies of the DNA fragment to be used as a probe.
After -the cells have been allowed to proliferate, the hybrid plasmids are isolated and purified, resulting in the isolation of many copies of the DNA
fragment.
Nucleie acid sequences to be attaehed to the solid supports could also be obtained syn-thetically or, if they occur in nature in sufficient quanti-ties, simply by isolation and purification.
It is also possible to attach nueleic aeid sequenees from an appropriately treated biologieal sample to the solid supports. In this case, the nucleie aeid sequences in solution would he those eomplementary to the sequences of interest in the sample; that is, the probe sequenees would be in solution.
Solid Support ~aterials The solid support to whieh the DNA or RNA is attached can be essentially any insoluble material to which the DNA or RNA can be covalently attaehed or irreversibly adsorbed; that is, the materlal must be reactive with the D~A or RNA or must adsorb a substance which can be eovalently linked to the DNA
or RNA. The solid support can be, for example, latex, ehareoal, eolloidal gold, bentonite or glass.
In addition, silica gel, controlled pore glass, red blood eells and liposomes can be used. In faet, any such particles to which nucleic aeids can be attaehed can be employed in the applieation of the present invention. Nucleic acids have reactive amino funetional groups ? as well as terminal phos-phate groups and reaetive hydroxyl groups in the sugar "backbone". In addition, ribose in RNA
~' ~ 3 ~
can be partially cleaved oxidatively (e.g., with periodate, as in Fischer, U.S. Patent 4,264,766) to produce a reactive aldehyde function. These re-active groups on -the nuc]eic acid can be reacted wi-th reactive groups on latex or other particles.
Glass or other particles can be derivatized to form reactive functional groups (see, for example, Weetall, U.S. Patent 3,652,761; Koster, et al., Tetrahedron Letters 24: 747 (1983)~ capable of reacting with nucleic acids and proteins. Nucleic acids can also be linked directly to polystyrene (e.g. ! Ito, et al.: Nucleic Acid Research 10: 755 (1982)). The solid support need not have a particu~
lar shape (configuration) but will often be spheri-cal. It must be small enough to remain in suspen~
sion and will generally have a large particle size relative to the molecular weight of the DNA or RNA
probe (e.g., less than 500 microns).
Binding oE Probe to Solid Support Nucleic acid sequences, either DNA or RNA, are attached to a solid support. For example, they can be covalently bound the binding can occur randomly along the length of the DNA or R~A, at the 5 end or at the 3 end. The sequences can also be bound to the solid support through a protein or other spacermaterial. Previously, a carbodiimide coupling reaction has been used by those in the field for the purpose of covalently linking DNA to solid supports, such a~s agarose (Sepharose~, aminoethyl-Sepharosc~
Sephadexes and cellulose. Allfrey, V.G. and A.
Inoue, In: Methods in Cell Biology 18: 253-270 (1978), This reaction produces a phosphodiester 13 ~ r~
bond between the phosphoryl group at the 5' end o~
the DNA and hydroxyl groups on the solid matrix.
In one embodiment o~ this invention, nucleic acid sequences bound to solid supports are linked to latex particles along the length of the fragments.
One method which can be used for covalent attachment is described in detail in Example 1. Nucleic acid sequences bound to latex particles using this method appear to be covalently attached randomly along their length. The method in Example l-is based on the method for forming an amide bond between latex and protein described by Dorman in U.S. Paten-t ~,045,3a4. There are three steps to the procedure.
First, carbox~lated latex particles are activated;
tha~ is, an active est.er is formed at the latex surface through reaction wi-th a water-soluble N~hydroxy cornpound (e.g., N~hydroxybenzotriazole or N-hydroxysuccinimide) and a water-soluble carbodi-imide (e.g., l-cyclohexyl-3-[2-morpholinoethyl]-carbodiimide methyl-p-toluene sulfonate (CMC)).
These materials are combined, stirred and cooled (e.g., to abou-t 2D-50C). As a result, an anhydride link is formed between the carboxyl group of the latex particle and the hydroxy nitrogen (NOH2) group o the hydroxybenzotriazole. Next the reaction mixture containing the hydroxybenzotriazole deriva-tive attached is cleaned by dialysis. In this way, unchanged reactants (e.g., carbodiimide and by-products~ are removed. Single stranded DN~ (or ~NA) can be covalently bonded to the activated latex particle by combining the latex-hydroxybenzotriazole complex with single stranded D~lA (or ~IA) and ~L3~ 3~ ~r agitating the combination (e.g., by rocking) at room temperature. The product of this procedure has been shown to be single stranded DN~ cov~lently attached to the la-tex particle at randcm along the length of the DNA. Similarly, this can also be done using RNA.
As mentioned, nucleic acids can also be at-tached to particles by being a-ttached to other "bridging" molecules which can be adsorbed or covalently attached to latex. Nucleic acids can be ~ovalently linked to polysaccharides through one of many known reactions (Allfrey, V.G. and A. Inoue, In: Methods in Cell Bioloqy 18: 253-270 ~1978)).
Polysaccharides can be partially oxidized to yield reactive aldehyde groups whic}l can, in turn, be reacted with particles haviny suitably rcac-t:ive groups such as amino groups (e.g., amino functional latex).
DNA can be covalently attached to proteins by numerous methods ~Nucleic Acid Research, 12: 3435 (1984)) and the proteins attached to latex or other particles using well known techniques. Synthetic polymers can also be used (Nucleic A _d Research 12:
3435 (1984); Litchfield, et al.: linical Chemistry 30: 1489 ~1984)).
~Iybridization of DNA Bound to Solid Support With Complementary D~IA
There are several methods which can be used to detect nucleic acids in a sample using DNA (or RNA) probes bound to a solid support according to the present invention. These are best described with reference to the EiguresO
. . .
As shown in Figure 2, the test or probe DNA or RNA (designatecl ~BC(+)~ can be bound to support material, such as latex particles, and DNA lor RNA) complementary to the probe DMA (designated .
A B C ~-)) can be bound to other latex particles.
When the sample containlng unknown nucl~ic acid ~e.g., ribosomal RNAI is contacted with a mixture of the two nucleic acid-bearing particles under condi~
tions appropriate for hybridization to occur, if the sample nucleic acid is complementary ~e.g., A B C
to that of the probe DNA, it will interfere with agglutination of the particles bearing the comple-mentary nucleic acid sequences. Particle agglutin-ation will be inhibited. The extent o interference with par-ticle agglutination is directly related to the amount of complementary nucleic acids in the sample. If there are only a few complementary sequences in the sample, particle agglutination will be interefered with to a lesser extent than if the sample contains a large number of sequences comple-mentary to sequences on the latex particles.
In another embodiment of the method of this invention, represented in Figure 1, probe nucleic acid is covalently bound to all latex particles.
The presence of complementary nucleic acid sequences in a sample will be detected when the latex parti-cles agylutinate. For example, one group of latex particles can have the nucleic acid sequences represented by ABC bound to them and another group sequences represented by D~ bound to them. I~ the sample nucleic acid contains the complementary sequences to ABCDEF le.g-, A B C D E F ) ~ 3 ~ c~
hybridization of the sample nucleic acids A B C
with the ABC on one par-ticle and of the sample nucleic acids ~ E F with the DEF on another particle will occur. As a result, agglutination of the particles will also occur. As shown in Figure 3, this would also occur if all latex particles have the entire sequence (ABCDEF) bound to them and the sample nucleic acids have the complementary sequences (A B C D E F ).
lOIn a further embodiment, represen~ed in Figure 4, particles of two different sizes can be used for -the attachment of probe DNA. For example, probe DNA
can be a-ttached to the larger partieles and its complement to the smaller particles. In the pre-senee of eomplementary DN~ or RNA in the sample, small partieles would not be agylutinated to large partieles and would pass through a filter of selected pore size. If the eomplementary sequences ; are not present in the sample, the probe DNA (bound to the larger particles) and its complement which is bound to the smaller partieles will hybridize, preventing the small partieles from passing through the filter.
It is also possible using the method of this invention to attach the unknown or sample nueleie aeid DNA or RNA to an aetivated latex particle.
This is represented in Figure 5. In this case, a specifie probe in solution is contaeted with the sample DNA-particle complex; the probe used can be tagged for purposes of detecting its presence. If the sample DNA or ~NA is complementary to the probe ~ 3 ~
D~A or RNA, hybridization of the nucleic acids and agglutination of the par-ticles will occur.
Measurement of Agglutination or ~ggrega~ion of Particles Having Bound DNA or ~NA as an Indica-tor of the Presence of Comp~ementary Sequences in a Sample Determination of agglutinatiorl or aggregation of particles having covalen-tly-bound DNA or RNA can be carried out by any method capable of detecting the degree of agglutination present after sample and probe have been contacted under conditions appropri-ate for hybridization to occur. For example, it can be carried out visually using the unaided eye (e.g., v.isualization against a black or other dark back-ground); microscopically; or by turbidimetricmeasurements. In addition, a particle counter having a size -threshhold can be used to detect aggregated/unaggregated particles. Selective counting techniques, which are well known in the art, make it possible -to count the number of part-icles in a given size range and -thus allow quanti~
tative assays to be carried out. See, for example, U.S. Patent 4,184,849 to C.~. Cambiaso et al., in which such techniques are described. It is also possible to use a ~ilter having a defined pore size;
the pore size is selected so as to allow nonaggre-gated particles to pass through but to prevent aggregated particles from doing so. See, for example, U.S. Patent 4,459,361 to ~I.L. Gefter.
Although it is possible, using filtration, to separate agglutinated particles from unagglutinated particles ~and thus detect hybridization of ~ 3 1 ~
-2~-complementary sequences), this approach is limi-ted in that the number of particles present must be large enough to allow visual detection. It is possible, however, using known -techniques, to enhance the visibility of the particles through selection of such properties as color, optical density and fluorescence. The particles can be enz~me labeled in such a way that the enzymes attached to the particle surfaces catalyze a color-producing change (thus aiding particle detection). Such amplification techniques are particularly useful when the nucleic acid sequences of in-terest are present in a sample in low concentratiolls.
This invention will now be more specifically described by the following examples.
Example 1 A. Preparation of single stranded complementary DNA
To prepare single stranded complementary DNA, the following method was used. A DNA sequence ~i~e., a portion of the src gene) was cloned into an ~13 bacteriophage using protocols described previ-ously. ~u, N. and J. Messing, The making of strand-25 -specific M13 probes. Gene, 17:271-277 (1982);
Messing, J., New M13 vectors for cloning, Methods in Enzymology-Recombinant DNA Techniques _:20-77 (1981). Two clones were isolated which contain the sequence cloned in opposite directions. The bac-teriophage produced by one of these clones contains single-stranded D~lA molecules which is partially ~3~ 3~$~
complementary to the DNA molecule of the other clone. The methods for using, cloning and growing commercially available M13 bacteriophage vectors exist (Amersham). For simplicity, (-~ is used to describe one ~13 bacteriophage cloned DN~ and (-) to describe the cloned DNA which contains its comple~
ment. Therefore, ~+) and (-) strands of DNA can hybridize by hydrogen bonding. Another method is to isolate the complementary DNA strands by preparative electrophoresis as described by Maniatls and co-workers. Maniatis, T. et al., Molecular Cloning - A
Laboratory Manual, Cold Spring Harbor Laboratory (1982).
B. A tivation of Carboxylated Latex Carboxylated latex used as the solid support in covalent binding with D~A was prepared according to the following technique, which is based on the method described by Dorman in U.S. Patent 4,045,384.
Activation of the carboxyl groups results from the reaction of the carboxylate latex with N-l-hydroxy-benzotriazole in the presence of CMC, according to the following reaction:
~3 1~3~
o~, o~
C
C~
~C-o~ 3 ) C-o- C, ~J ~ IJ
~ llo~
,~
-C-~H-C~J,C1~ l .
~3~L3~
Specifically, 0.2 ml. of an ~ hydroxybenzo-triazole solution was added to I ml. of carboxylate la-tex (1 microrl in diameter, 2.5% solids). (The N
hydroxybenzotriazole solution was made by dissolving 93 mg. of Aldrich ~-hydroxybenzotriazole in 1.6 ml.
dimethylformamide; this was diluted to 4 ml. with water.) The combination was placed in an ice water bath and 0.1 ml. of CMC (100 mg. CMC solution in 2 ml. water at 0C) was added dropwise. The mixture was stirred in the cold Eor four hours or overnight.
Cleaning of the latex (removal of the unreacted products of the reaction, e.g., urea, as shown above) was accomplished by dialyzing the mix-ture overnight agains~ 0.1 molar (M) sodium chloride (~laCl) at 4C. An additional 2 ml. of O.lM NaCl was added to the dialysis bag.
The mix-ture was placed in Eppendorf -tubes (1 ml. each) and sonicated for 10 seconds. They were spun and resuspended three times in water and then resuspended in 50 mM phosphate buffer at pH 8Ø
Covalent Bonding of D~lA -to the Modified Latex DNA to be bonded to the latex particles was added to the dialyzed particles described above.
The DNA prepared as in part A was added while the 2S particles were being stirred in an ice water bath or at 5~ Also present at that time was 1 m1. of pll 8.0 phospha-te buffer and 0.1 ~I NaCl solution. About 0.06 ml. of the N-hydroxybenzotriazole solution (prepared as described above) was also added to aid the forward reaction. The pll of the mixture ~G.83 was raised to 7.2 by the addition of 0.5~1 dibasic sodium phosphate. The mixture was stirred for 5 ~3~$~
-2~-days at about 4C and washed with clistilled water containing azide.
Evaluation of the la-tex par-ticles prepared according to the method described above was carried out. The latex particles were spun down in Eppen-dorf tubes and washed three times with 0.1~ SDS;
each time -they were resuspended in 1 ml. of 0.1~
SDS. Microscopic assessment showed that most of the particles were monomers or dimers.
D. Agglutination of Latex Partieles by Hybridiza-tiOIl of (~) Stand Covalently Bound -to Latex to (-) Strand DNA in Solution -llybridization of (~) strand DNA to (-~) strand DNA covalently bound -to latex partieles was carried out. About 0.1 ml of latex (2~ solids) to whi.ch (-~) strand DNA was covalently bound was placed ln each of three tubes. The solid latex particles were pelleted by cen-trifugation and resuspended in 50 mieroliters of 0.4~!1 sodium phosphate buffer ip~ 7.8) and 0.1~ SDS containing one o the following:
o DNA
(2) (+) strand DNA (0.5 micrograms) (3) (-) strand DNA (0.5 micrograms) The three tubes were incubated at 60C for 10 to 12 hours. ~fter the incubation the latex was pelleted again and resuspended in 0.1~ SDS.
Approximately 10 microliters were placed on a glass microscope slide and examined microscopically under oil immersion at 100 X m~gni~ication under ~ cover slip. The examination showed the following: (1) Mostly monomeric: a few climers (2~ ~lostly monomer~s;
--~s-a few dimers (3) Few monomers; many particles in which 4 to 10 latex particles have agglutinated.
These results demonstrate tha-t (-) strand DNA in solution can cause latex which has (~) strand DNA
covalently attached to it -to agglut;Lnate.
Example 2 The procedure described in Example 1 was used excep-t that -the latex preparation was re~uspended in 50 microliters of 0.4 M sodium phosphate bu~fer, 0.1~ SDS containing tl) Denatured calf thymus DNA (1.5 ug) (2) (-~ strand DNA (5 ug) (3) (-) strand DPlA (0.5 ug) -~ calf thymus DNA
(1.5 ug) ~Iicroscopic observations showed the followiny:
(1~ Mos-tly monomers; a few dimers (2) Very large aggregates; many greater than 50-100 particles, visible using the unaided eye (3) Few monomers; many aggregates (having) 4 to 6 latex particles.
These results demonstrate that: (1) non-complemen-tary DNA will not cause DNA which has (+) strand DNA
covalently bound to it to agglutinate; (2) a large amount of ~-) strand DNA (5 ug) in solution will cause a lot of visible agglutination while a little ; (-) strand DNA in solu-tion (0.5 ug) will cause only a little agglutination; (3) heterologous, noncomple-mentary thymus DNA will not interfere with agglutination of lateY. with (+) strand DNA
covalently attached to it by ~-) strand DNA in solution.
!l .
~ 3 ~
-2~-The main conclusion to he drawn from bo-th of these examples is that under the conditions des-cribed DNA in solution can hybridize to comple-mentary DNA attached to a solid support and cause the latex to agglutinate.
Example 3 Detection of Nucleic Acid Sequences In A
Biological Sample Vsing Covalently Bound DNA
Sequences RNA can be extracted from a sample of milk and used to cause the agglutination of a latex that has a probe specific for ribsomal RNA (vRNA3 attached to it. Such a probe is DNA or ~NA complemen-tary to the sequences of vRNA of organisms which occur in milk.
This can be carried out as follows:
(1) To 10 ml of skim milk add SDS to 0.1~, Proteinase K to 200 ug/ml (2) Incubate at 60~C overnight (3) Add 10 ml of liquified equilibrated phenol (4) Extract and centrifuge (5) Remove aqueous phase and add DNase to 100 ug/ml (6) Repeat steps 3 and 4 (7) Take aqueous phase; add 10 ml of isoamyl alcohol and chloroform mixed in a 1 to 24 volume/volume mixture (8) Repeat step 4 (9) Repeat steps 7 and 8 ~10) Remove aqueous phase and bring to 0.1 ~l sodium chloride. Add 20 mls ethyl alcohol (11) Bring to -20C for 10~12 hours (12) Centrifuge at 15, noo g.
(13) ~esuspend pellet in 5~ microliters containillg 0.4 t~ pllo~L~Ilate ~uffer, O.l~
~ 3 ~
SDS and latex with a rRN~ probe covalently attached as described in example lB.
(14~ Incubate at 60C for 10 to 12 hours (15) Observe the latex microscopically or visually Visual (microscopic) evaluation shows that there are few monomers; most are 5 to 100 agglutinated latex particles.
Industrial Applicability Nucleic acid probes and hybridization assays according to this invention have a variety of possible applications in which the ability to detect, quantify and/or identify complementary nucleic acid sequences of interest .in biological samples of all kinds is of great value. For ex-ample, they are useEul in a research context as tools for studying gene structure and inheritance.
In addition, they are useful in clinical settings for the detection and identification of infectious agents and for prenatal diagnosis of genetic dis-orders. Finally, DNA probes have utility in the diagnosis of cancer (by providing information on the structure of oncogenes); in tissue typing; in veterinary and plant diagnos-tics; and in food testing (by providing a quicker, more convenient means of testing for the presence of pathogens~.
Equivalents Those skilled in the art will recognize, or be able to ascertain using no more than routine experi-mentation, many equivalents to the specific \
~3~3~
embodiments of the invention described herein. Such equivalen-ts are intended -to be encompassed by the following cl.aims.
.
' .
Claims (21)
1. A method of determining the presence or absence of nucleic acid sequences in a sample, comprising detecting the degree of agglutination or inhibition of agglutination of particles having bound thereto nucleic acid sequences complementary to those whose presence or absence in the sample is to be determined.
2. The method of Claim 1 in which the complementary nucleic acid sequences are covalently bound to the particles or to a material which is adsorbed to or covalently bound to the surface of the particles.
3. A method of determining the presence or absence of nucleic acid sequences in a biological sample, comprising the steps of, a) contacting the biological sample with particles having covalently bound thereto nucleic acid sequences complementary to those whose presence or absence is to be determined in the biological sample; and b) determining the degree of agglutination of the particles.
4. A method of determining the presence of nucleic acid sequences in a sample, comprising detecting the hybridization of nucleic acid sequences bound to particles and nucleic acid sequences in the sample which are complementary to the bound sequences by detecting the degree of agglutination of the particles.
5. The method of Claim 4 in which the nucleic acid sequences bound to particles are covalently bound to latex particles or are covalently bound to a material which is adsorbed to or covalently bound to the surface of latex particles.
6. A method of detecting nucleic acid sequences in a sample, comprising the steps of:
a) covalently bonding to particles nucleic acid sequences complementary to the nucleic acid sequences to be detected in the sample, the diameter of said particles being less than about 500 microns, b) treating the sample to make the nucleic acids present in the sample available for hybridization with complementary nucleic acid sequences;
c) contacting the particles having covalently bound nucleic acid sequences and the treated sample under conditions appropriate for hybridization of complementary nucleic acid sequences; and d) detecting hybridization of nucleic acid sequences bound to the particles with complementary nucleic acid sequences in the sample by determining the degree of agglutination of the particles.
a) covalently bonding to particles nucleic acid sequences complementary to the nucleic acid sequences to be detected in the sample, the diameter of said particles being less than about 500 microns, b) treating the sample to make the nucleic acids present in the sample available for hybridization with complementary nucleic acid sequences;
c) contacting the particles having covalently bound nucleic acid sequences and the treated sample under conditions appropriate for hybridization of complementary nucleic acid sequences; and d) detecting hybridization of nucleic acid sequences bound to the particles with complementary nucleic acid sequences in the sample by determining the degree of agglutination of the particles.
7. A method of Claim 6 in which the particles are latex particles.
8. A method of detecting nucleic acid sequences in a sample, comprising the steps of:
a) contacting the sample with 1) particles having bound thereto nucleic acid sequences complementary to the sequences to be detected and 2) particles having bound thereto nucleic acid sequences complementary to the sequences bound to the particles in (1), under conditions appropriate for nucleic acid hybridization and b) determining the degree of agglutination of the particles.
a) contacting the sample with 1) particles having bound thereto nucleic acid sequences complementary to the sequences to be detected and 2) particles having bound thereto nucleic acid sequences complementary to the sequences bound to the particles in (1), under conditions appropriate for nucleic acid hybridization and b) determining the degree of agglutination of the particles.
9. The method of Claim 8 in which nucleic acid sequences are covalently bound to the particles or are covalently bound to a spacer molecule which is adsorbed to or covalently bound to the surface of the particles.
10. A method of Claim 9 in which the particles are latex particles.
11. A method of detecting nucleic acid sequences in a sample, comprising the steps of:
a) bonding to particles nucleic acid sequences complimentary to nucleic acid sequences to be detected in the sample;
b) bonding nucleic acid sequences which are complementary to those bound to the particles of (a) to inert particles of smaller size than the particles of (a);
c) contacting the particles of (a) and the particles of (b) with the sample under conditions appropriate for hybridization of complementary nucleic acid sequences to occur; and d) determining the degree of agglutination of the particles of (a) with the particles of (b).
a) bonding to particles nucleic acid sequences complimentary to nucleic acid sequences to be detected in the sample;
b) bonding nucleic acid sequences which are complementary to those bound to the particles of (a) to inert particles of smaller size than the particles of (a);
c) contacting the particles of (a) and the particles of (b) with the sample under conditions appropriate for hybridization of complementary nucleic acid sequences to occur; and d) determining the degree of agglutination of the particles of (a) with the particles of (b).
12. In a method of detecting nucleic acid sequences in solution using nucleic acid probes, the improvement comprising the use of particles having bound thereto nucleic acid sequences complementary to nucleic acid sequences to be detected in the solution.
13. In a method of detecting nucleic acid sequences in solution using nucleic acid probes, the improvement comprising detecting the degree of agglutination of particles having bound thereto nucleic acid sequences complementary to the nucleic acid sequences to be detected.
14. A method of detecting nucleic acid sequences in a sample, comprising the steps of:
a) contacting particles having bound thereto nucleic acid sequences from a sample with nucleic acid sequences complementary to those to be detected and b) determining the degree of agglutination of the particles.
a) contacting particles having bound thereto nucleic acid sequences from a sample with nucleic acid sequences complementary to those to be detected and b) determining the degree of agglutination of the particles.
15. A kit for detection of nucleic acid sequences in a sample by determination of agglutination, comprising a container and latex particles having covalently bound thereto nucleic acid sequences complementary to the nucleic acid sequences to be detected.
16. Particles having bound thereto nucleic acid sequences.
17. The particles of Claim 16 to which the nucleic acid sequences are covalently bound to the surface of the particles or covalently bound to a spacer material. which is adsorbed to or covalently bound to the surface of the particles.
18. The particles of Claim 17 in which the particles are latex particles having a diameter of less than about 500 microns.
19. Latex particles having nucleic acid sequences bound thereto, said sequences being either covalently bound to the surface of the latex particles or covalently bound to a spacer material which is adsorbed to or covalently bound to the surface of the latex particles.
20. In a solid support having attached thereto nucleic acid sequences, the improvement comprising latex particles having a diameter of less than about 500 microns and having the nucleic acid sequences either covalently bound to the surface thereof or covalently bound to a material which is adsorbed to the surface thereof.
21. A method of detecting nucleic acid sequences in a sample, comprising the steps of:
a) bonding to particles nucleic acid sequences complimentary to nucleic acid sequences to be detected in the sample;
b) bonding nucleic acid sequences which are complementary to those bound to the particles of (a) to inert particles of smaller size than the particles of (a);
c) contacting the particles of (a) and the particles of (b) with the sample under conditions appropriate for hybridization of complementary nucleic acid sequences to occur; and d) determining the presence or absence of agglutination of the particles of (a) with the particles of (b).
a) bonding to particles nucleic acid sequences complimentary to nucleic acid sequences to be detected in the sample;
b) bonding nucleic acid sequences which are complementary to those bound to the particles of (a) to inert particles of smaller size than the particles of (a);
c) contacting the particles of (a) and the particles of (b) with the sample under conditions appropriate for hybridization of complementary nucleic acid sequences to occur; and d) determining the presence or absence of agglutination of the particles of (a) with the particles of (b).
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US83610086A | 1986-03-04 | 1986-03-04 | |
| US836,100 | 1986-03-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1313485C true CA1313485C (en) | 1993-02-09 |
Family
ID=25271242
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA000530996A Expired - Fee Related CA1313485C (en) | 1986-03-04 | 1987-03-03 | Detection of nucleic acid sequences using particle agglutination |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP0259453A1 (en) |
| JP (1) | JPS63502875A (en) |
| CA (1) | CA1313485C (en) |
| WO (1) | WO1987005334A1 (en) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL85551A0 (en) * | 1987-04-01 | 1988-08-31 | Miles Inc | Rapid hybridization assay and reagent system used therein |
| US5359100A (en) * | 1987-10-15 | 1994-10-25 | Chiron Corporation | Bifunctional blocked phosphoramidites useful in making nucleic acid mutimers |
| US5124246A (en) * | 1987-10-15 | 1992-06-23 | Chiron Corporation | Nucleic acid multimers and amplified nucleic acid hybridization assays using same |
| US5104791A (en) * | 1988-02-09 | 1992-04-14 | E. I. Du Pont De Nemours And Company | Particle counting nucleic acid hybridization assays |
| CA2032203C (en) * | 1989-12-29 | 2009-05-19 | Christine L. Brakel | Amplification capture assay |
| US5147777A (en) * | 1990-06-18 | 1992-09-15 | Eastman Kodak Company | Biologically active reagents prepared from carboxy-containing polymer, analytical element and methods of use |
| DE69112309T2 (en) * | 1990-06-28 | 1996-01-25 | Wakunaga Seiyaku Kk | Procedure for nucleic acid detection. |
| GB9019512D0 (en) * | 1990-09-06 | 1990-10-24 | Ici Plc | Assay method |
| US5578498A (en) | 1991-05-22 | 1996-11-26 | Behringwerke Ag | Metal chelate containing compositions for use in chemiluminescent assays |
| US6251581B1 (en) | 1991-05-22 | 2001-06-26 | Dade Behring Marburg Gmbh | Assay method utilizing induced luminescence |
| JPH0538300A (en) * | 1991-08-07 | 1993-02-19 | Hitachi Ltd | Method and automatic analyzer for measuring nucleic acid |
| FR2720508B1 (en) * | 1994-05-25 | 1996-08-09 | Rech Developp Activ Commun | Method for detecting an analyte in a sample and device for implementing the method. |
| US5747256A (en) * | 1995-12-19 | 1998-05-05 | Beckman Instruments, Inc. | Homogeneous DNA probe titration assay |
| WO1997023647A1 (en) * | 1995-12-22 | 1997-07-03 | Behringwerke Aktiengesellschaft | Homogeneous amplification and detection of nucleic acids |
| WO1999023258A1 (en) * | 1997-10-31 | 1999-05-14 | Gen-Probe Incorporated | Methods of nucleic acid detection |
| JP2017501719A (en) * | 2013-12-23 | 2017-01-19 | ザ ユニバーシティ オブ クイーンズランドＴｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｑｕｅｅｎｓｌａｎｄ | Nucleic acid detection method and kit |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4713326A (en) * | 1983-07-05 | 1987-12-15 | Molecular Diagnostics, Inc. | Coupling of nucleic acids to solid support by photochemical methods |
| CA1223222A (en) * | 1984-02-22 | 1987-06-23 | Nanibhushan Dattagupta | Immobilized nucleic acid-containing probes |
| US4605686A (en) * | 1984-03-13 | 1986-08-12 | Sekisui Kagaku Kogyo Kabushiki Kaisha | Latex for immunoserological tests and a method for the production of the same |
| JPS61501746A (en) * | 1984-04-05 | 1986-08-21 | ライフ テクノロジ−ズ，インコ−ポレイテツド | Nucleic acid immobilization method |
-
1987
- 1987-03-03 CA CA000530996A patent/CA1313485C/en not_active Expired - Fee Related
- 1987-03-03 JP JP50161987A patent/JPS63502875A/en active Pending
- 1987-03-03 EP EP19870901958 patent/EP0259453A1/en not_active Withdrawn
- 1987-03-03 WO PCT/US1987/000414 patent/WO1987005334A1/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JPS63502875A (en) | 1988-10-27 |
| WO1987005334A1 (en) | 1987-09-11 |
| EP0259453A1 (en) | 1988-03-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1313485C (en) | Detection of nucleic acid sequences using particle agglutination | |
| JP7408229B2 (en) | Polynucleotide capture materials and methods for their use | |
| JP2862547B2 (en) | Polycationic support for nucleic acid purification, separation and hybridization | |
| WO1990002205A1 (en) | Detection of nucleic acid sequences using particle agglutination | |
| EP0265244B1 (en) | Target and background capture methods and apparatus for affinity assays | |
| US4925785A (en) | Nucleic acid hybridization assays | |
| EP0336454B1 (en) | Nucleic acid hybridization assay | |
| CA1272940A (en) | Homogenous assay for specific polynucleotides | |
| JPH0746999A (en) | Water-insoluble reagent, nucleic acid probe and test kid and diagnozing and refining method | |
| JPH0919292A (en) | Magnetic carrier for binding nucleic acid and nucleic acid isolation using the same | |
| AU706205B2 (en) | Homogeneous DNA probe titration assay | |
| NZ223700A (en) | Method of assaying nucleic acids | |
| EP0204510A2 (en) | Amplification of hybridization signals by employing complementary DNA strands | |
| CA2026573A1 (en) | Nucleic acid test article and its use to detect a predetermined nucleic acid | |
| JPH0630637B2 (en) | Nucleic acid detection method by separation | |
| CA1309932C (en) | Nucleic acid hybridization technique and kit therefor | |
| EP0425217A2 (en) | A hybridization assay for campylobacter rRNA | |
| US6027879A (en) | Detection and isolation of nucleic acid sequences using a bifunctional hybridization probe | |
| KR920007664B1 (en) | Methods for purification amplification and detection of a nucleic acid | |
| US5783387A (en) | Method for identifying and quantifying nucleic acid sequence aberrations | |
| KR20190114360A (en) | Method and System for Assaying Genome Using Visually Detectable Particles | |
| KR20200095041A (en) | System for Assaying Pathogens Integrated with Smart Devices | |
| EP0421469A2 (en) | Method for separating nucleic acid | |
| JPH06113897A (en) | Method for measuring nucleic acid | |
| JP2002181821A (en) | Multiple test multiplexing suspension and multiple test multiplexing method using it |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKLA | Lapsed |